Investing Profile

Andrew Kozlov

InvestorVCFounder
Managing Partner, Co-Founder at 4BIO Capital
Photo of Andrew Kozlov, Managing Partner at 4BIO Capital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Mckinsey & Company Network
297 CONNECTIONS
The University of Chicago Booth School of Business Network
137 CONNECTIONS
HSBC Network
103 CONNECTIONS
cb
4BIO Capital Managing Partner
$100K - $5.0M
$1.5M
2
$50M
CompanyStageDateRound SizeTotal Raised
Ascend Gene & Cell Therapies
Series AMar 2023$66M
$66M
Co-investors: Eric Shiozaki (DCVC (Data Collective)), Bali Muralidhar (Abingworth), Andrew Sinclair (Abingworth)
IAG, Image Analysis Group
Series UnknownApr 2015$5M
$5M
Director of St. Petersburg Affiliate Profine GroupPresent
Summer Associate Mckinsey & CompanyPresent
Associate, Investment Banking, FIG HSBCPresent
Board Member AssertioPresent
Board Member IMAGE ANALYSIS GROUPPresent
Board Member Vascular Flow Technologies LtdPresent
Board Member Redpin TherapeuticsPresent
Board Member Ascend Advanced TherapiesPresent
Board Member TrogenixPresent
Partner Enso VenturesPresent
Managing Partner, Co-Founder 4BIO CapitalPresent
Saint Petersburg State University Diploma, Cum Laude Economics, International Economic Relations
Saint Petersburg State University Diploma Cum Laude, Economics, International Economic Relations
University of Hamburg Economics Study abroad programme
The University of Chicago Booth School of Business MBA Concentrations: Accounting and Finance, Entrepreneural Finance, Oraginzational Behavior